Pharmacogenomic biomarker information in FDA-approved paediatric drug labels.


Gene maturation differs between paediatric and adult populations, and the extrapolation of adult pharmacogenomic information to paediatrics is not always appropriate. We sought to determine the extent of paediatric pharmacogenomic trial translation into US FDA-approved labels and to evaluate needs for biomarker studies. Using FDA's Table of Genomic… (More)
DOI: 10.1111/bcpt.12341


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics